Analyst Price Targets — CRON
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 14, 2026 12:07 pm | Nadine Sarwat | Bernstein | $2.30 | $2.70 | StreetInsider | Cronos Group (CRON) PT Raised to $2.30 at Bernstein |
| August 9, 2024 5:54 am | Lisa Lewandowski | Bank of America Securities | $2.30 | $2.32 | StreetInsider | Cronos Group (CRON) PT Lowered to $2.30 at BofA Securities |
| September 30, 2022 7:48 am | — | Barclays | $3.50 | $2.93 | Benzinga | Barclays Maintains Equal-Weight on Cronos Group, Lowers Price Target to $3.5 |
| May 11, 2022 6:04 am | Matt Bottomley | Canaccord Genuity | $4.50 | $3.18 | TheFly | Cronos Group upgraded to Hold from Sell at Canaccord |
Latest News for CRON
Cronos Group (NASDAQ: CRON) reported what executives described as a record year in 2025, with organic net revenue growth of 25% and record results for quarterly and full-year net revenue, full-year gross profit, and adjusted EBITDA. Management pointed to strong consumer demand in Canada, continued expansion in Israel, and growing contributions from other international markets as
Cronos Group Inc. (CRON:CA) Q4 2025 Earnings Call Transcript
Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million ; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million
Cronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with $784M in cash. CRON's acquisition of CanAdelaar and expansion into Europe and Australia position it for accelerated growth and margin improvement over the next 24-36 months. GrowCo's completed capacity expansion and 70% flower volume increase in 2026 are expected to drive top-line and EBITDA…
The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum. Because of that, Canadian operators with U.S. exposure are drawing attention. Many investors are watching companies positioned for cross-border expansion.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CRON.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.